MedPath

BOIRE GILLES

🇫🇷France
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

3

Active:0
Completed:1

Trial Phases

1 Phases

Phase 4:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials

Phase 4
1 (100.0%)

Assessment of Response to Treatment of Osteoporosis With Oral Bisphosphonates in Patients With Muscular Dystrophy

Phase 4
Completed
Conditions
Osteoporosis
Cystic Fibrosis
Muscular Dystrophy
Interventions
Drug: Bisphosphonate treatment
First Posted Date
2013-06-20
Last Posted Date
2018-01-09
Lead Sponsor
Gilles Boire
Target Recruit Count
11
Registration Number
NCT01882400
Locations
🇨🇦

Centre hospitalier universitaire de Sherbrooke, Sherbrooke, Quebec, Canada

Prognostic Evaluation of Inflammatory Polyarthritis of Recent Onset

Recruiting
Conditions
Inflammatory Arthritis
Rheumatoid Arthritis
First Posted Date
2007-08-07
Last Posted Date
2025-03-25
Lead Sponsor
Gilles Boire
Target Recruit Count
1000
Registration Number
NCT00512239
Locations
🇨🇦

Centre hospitalier universitaire de Sherbrooke, Sherbrooke, Quebec, Canada

Synovial Fluid Bank From Arthritic Patients

Recruiting
Conditions
Arthritis
First Posted Date
2007-08-07
Last Posted Date
2025-03-25
Lead Sponsor
Gilles Boire
Target Recruit Count
500
Registration Number
NCT00512343
Locations
🇨🇦

Centre hospitalier universitaire de Sherbrooke, Sherbrooke, Quebec, Canada

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.